AXSM — AXSOME THERAPEUTICS INC

Ownership history in Deep Track Capital, LP  ·  10 quarters on record

This page tracks every 13F SEC filing in which Deep Track Capital, LP reported a position in AXSOME THERAPEUTICS INC (AXSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.45% (2024 Q2)
Avg. % of fund
2.69%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,150,000 +250,000 +27.8% 3.74% $210.0M $182.64
2025 Q3 ADDED 900,000 +98,629 +12.3% 3.05% $109.3M $121.45
2025 Q2 ADDED 801,371 +601,371 +300.7% 2.68% $83.7M $104.39
2024 Q3 REDUCED 200,000 -657,219 -76.7% 0.57% $18.0M $89.87
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AXSM price (monthly, adj. close)

Other funds also holding AXSM

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 59.3% IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 4.96% Tri Locum Partners LP 3Y 4.78% PFM Health Sciences, LP 3Y 7Y 4.58% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.52% First Turn Management, LLC 4.32% SUPERSTRING CAPITAL MANAGEMENT LP 3.66% Rhenman & Partners Asset Management AB 3Y 7Y 1.96% Privium Fund Management B.V. 3Y 1.91% Seven Fleet Capital Management LP 1.8%
← Back to Deep Track Capital, LP Holdings